Merck Limited
Add to watch list to get report alerts
BSE Code:
500126
NSE Code:
PGHL
Business Profile
Business Profile
E Merck (India) (MERCK) was incorporated in 1967 to take over the business of the Indian branch of Emeda Exports with all its assets and liabilities. The company is a 51% subsidiary of Merck KGaA, Germany, a player in vitamin formulations. MERCK has five divisions - pharma, reagents, bulk drugs, diagnostics and pigments. The products manufactured are specialities in the group of neurotropics, dermatology, antibiotics, nasal decongestants, basic vitamins, imaging agents, laboratory and fine chemicals, etc. E-Merck started operations as a manufacturer of pharmaceutical specialities and over the years, it has diversified its product range to include basic drugs, fine and industrial chemicals, and diagnostics.
The product mix of MERCK includes Cod polybion syrup, Pedimune - P, Osto Polybion syrup, Flexi joint capsules, Livogen drops, Concor AM 2.5 TABS, Concor AM 5 TABS etc.
E Merck (India) is gradually increasing its presence in cardiovascular, anti-infectives and anti-malarial segments to widen its therapeutic reach. The investing associates of E-Merck include Chemitra GmbH, Germany, Emedia Export Company, Germany and Merck Internationale Beteiligungen GmbH, Germany and has Chemische Fabrik Lehre, Germany, EMD Biosciences Inc., U.S.A. Merck B Cie KG, Switzerland Seven Seas, U. K. P. T. Merck Indonesia et al as its subsidiaries. Life Science and Analytics (excluding Bulk Drugs) Business, which formed part of the Chemicals segment was sold with effect from April 1, 2006.
MERCK proposes to make efforts to develop innovative, commercially viable processes know-how for both active pharmaceutical ingredients and dosage forms and also for improving the shelf life/stability, quality, convenience, meeting regulatory compliances, continuous RED initiatives. E Merck (India) is located at Mumbai, India.
Financials
The company announced a phenomenon drop in standalone net profit for the quarter ended March 2009. During the quarter, the profit of the company declined 46.80% to Rs 86.11 million from Rs 161.87 million in the same quarter last year. Net sales for the quarter rose 18.58% to Rs 988.49 million, while total income for the quarter rose 16.58% to Rs 1,098.19 million, when compared with the prior year period. It reported earnings of Rs 5.11 a share during the quarter, registering 46.77% decline over prior year period.